Biotech Catalysts This Week: FDA Decisions, Readouts & Earnings (Jun 28–Jul 5, 2026)
Here’s what’s on the biotech calendar for June 28–July 5: 2 FDA decision dates, 15 trial catalysts, and 0 earnings reports from tracked companies.
💊 FDA Decisions (PDUFA Dates)
| Date | Ticker | Drug | Indication | Type |
|---|---|---|---|---|
| 2026-06-29 | UNCY | — | hyperphosphatemia in patients | NDA |
| 2026-06-30 | VRDN | — | patients with TED | BLA |
📡 Run-up Radar Highlights
Stocks entering the pre-catalyst window with the strongest setups (full radar is a Premium feature):
- CELC: NDA in 19 days, score 79/100
- VERA: BLA in 9 days, score 79/100
- UNCY: NDA in 1 days, score 79/100
📈 Last Week’s Biggest Gainers
- APGE +46.66% (volume 32.0x average)
- TECH +20.08% (volume 18.8x average)
Track your tickers on the BioRadar dashboard →
This digest is for informational purposes only and is not investment advice. Always do your own research.